RE: Quiet7 Apr 2021 12:57
Yes antiegn lft but next gen. The money is moving to accurate decentralised versatile diagnostics. Q32 and Q16 were first gen, adding promate made it next generation....now what is the next move in the series here? A cartridge type accurate rapid test as Tay alluded to on twitter?
I am still very sceptical about lft as they are not accurate at all and give false readings both ways hence locking people up wrongly and making people think they are not infected when they are and thus spreaders. The margins on lft are also very low if the government only want to spend £5. When you think of the packaging, distribution, materials, labour and then outsourcing to a 3rd party - as i previously said it maybe 50p profit per test max? so you would need to sell 100m of these to make 50m cash?